Preclinical and Clinical Researchers play a critical role in the drug development process, ensuring that new treatments are both effective and safe before they reach the market. Preclinical researchers conduct studies in laboratories and animal models to gather the initial data on a drug’s safety, efficacy, and pharmacokinetics. These early-stage studies help identify the potential risks and benefits of a drug, as well as the optimal dosage and administration routes. Preclinical research serves as the foundation for clinical trials, where drugs are tested in human subjects for the first time. Preclinical studies are essential for laying the groundwork for clinical research, ensuring that only the most promising candidates advance to human testing.
After passing preclinical testing, clinical researchers take over to lead trials in human volunteers and patients. Clinical researchers are responsible for designing and conducting clinical trials, which are divided into phases to evaluate the drug’s safety, effectiveness, and long-term impacts. Clinical researchers ensure that all trials are conducted ethically and in compliance with regulatory guidelines, gathering critical data to support drug approval by regulatory agencies. By analyzing data from clinical trials, these researchers provide vital information that helps determine whether a drug can be approved for widespread use. As the demand for more personalized and targeted therapies grows, preclinical and clinical researchers are essential in transforming scientific discoveries into real-world treatments that benefit patients globally.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico